"Next trial from ACTIV-3/TICO published: Effficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial. Thanks to Christina Barkauskas, Eleftherios Mylonakis &amp; Garyfallia Poulakou for leading. https://t.co/SEZK5K0Lln"